Application 208944

Type: NDA
Sponsor: ADAMAS PHARMA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	GOCOVRI	AMANTADINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 68.5MG BASE	Yes	No
002	GOCOVRI	AMANTADINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 137MG BASE	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N208944-001	GOCOVRI	AMANTADINE HYDROCHLORIDE	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24
N208944-002	GOCOVRI	AMANTADINE HYDROCHLORIDE	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24

Orange Book patents#

Current patent rows page 1 of 1 · 34 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N208944-001	8389578	2028-01-22	U-2105		2017-09-21
N208944-001	11197835	2030-12-02	U-2106		2022-01-12
N208944-001	8741343	2030-12-02	U-2106		2017-09-21
N208944-001	9867791	2030-12-02	U-2106		2018-01-16
N208944-001	9867792	2030-12-02	U-2106		2018-01-16
N208944-001	9867793	2030-12-02	U-2106		2018-01-16
N208944-001	9877933	2030-12-02	U-2224		2018-01-30
N208944-001	10646456	2034-06-17	U-2808		2020-07-14
N208944-001	11903908	2034-06-17	U-3822		2024-03-08
N208944-001	10154971	2034-12-04	U-2459		2018-12-18
N208944-001	11065213	2038-08-23		Drug product	2021-07-20
N208944-001	11077073	2038-08-23	U-2106		2021-08-04
N208944-001	11077073	2038-08-23	U-2224		2021-08-04
N208944-001	11077073	2038-08-23	U-3180		2021-08-04
N208944-001	12233033	2038-08-23	U-2106		2025-03-25
N208944-001	12233033	2038-08-23	U-2224		2025-03-25
N208944-001	12233033	2038-08-23	U-3180		2025-03-25
N208944-002	8389578	2028-01-22	U-2105		2017-09-21
N208944-002	11197835	2030-12-02	U-2106		2022-01-12
N208944-002	8741343	2030-12-02	U-2106		2017-09-21
N208944-002	9867791	2030-12-02	U-2106		2018-01-16
N208944-002	9867792	2030-12-02	U-2106		2018-01-16
N208944-002	9867793	2030-12-02	U-2106		2018-01-16
N208944-002	9877933	2030-12-02	U-2224		2018-01-30
N208944-002	10646456	2034-06-17	U-2808		2020-07-14
N208944-002	11903908	2034-06-17	U-3822		2024-03-08
N208944-002	10154971	2034-12-04	U-2459		2018-12-18
N208944-002	11065213	2038-08-23		Drug product	2021-07-20
N208944-002	11077073	2038-08-23	U-2106		2021-08-04
N208944-002	11077073	2038-08-23	U-2224		2021-08-04
N208944-002	11077073	2038-08-23	U-3180		2021-08-04
N208944-002	12233033	2038-08-23	U-2106		2025-03-25
N208944-002	12233033	2038-08-23	U-2224		2025-03-25
N208944-002	12233033	2038-08-23	U-3180		2025-03-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD	2017-08-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N208944-001	GOCOVRI	EQ 68.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	2017-08-24	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N208944-002	GOCOVRI	EQ 137MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	2017-08-24	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208944-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208944-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208944-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208944-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208944-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208944-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208944-001	AB	1	`d06236e962d9…`

Observed Orange Book patent history#

Patent history page 1 of 42 · 1,644 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N208944-001	8389578	2028-01-22	U-2105		2017-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	11197835	2030-12-02	U-2106		2022-01-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	8741343	2030-12-02	U-2106		2017-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	9867791	2030-12-02	U-2106		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	9867792	2030-12-02	U-2106		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	9867793	2030-12-02	U-2106		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	9877933	2030-12-02	U-2224		2018-01-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	10646456	2034-06-17	U-2808		2020-07-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	11903908	2034-06-17	U-3822		2024-03-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	10154971	2034-12-04	U-2459		2018-12-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	11065213	2038-08-23		Drug product	2021-07-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	11077073	2038-08-23	U-2106		2021-08-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	11077073	2038-08-23	U-2224		2021-08-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	11077073	2038-08-23	U-3180		2021-08-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	12233033	2038-08-23	U-2106		2025-03-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	12233033	2038-08-23	U-3180		2025-03-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-001	12233033	2038-08-23	U-2224		2025-03-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	8389578	2028-01-22	U-2105		2017-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	11197835	2030-12-02	U-2106		2022-01-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	8741343	2030-12-02	U-2106		2017-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	9867791	2030-12-02	U-2106		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	9867792	2030-12-02	U-2106		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	9867793	2030-12-02	U-2106		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	9877933	2030-12-02	U-2224		2018-01-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	10646456	2034-06-17	U-2808		2020-07-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	11903908	2034-06-17	U-3822		2024-03-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	10154971	2034-12-04	U-2459		2018-12-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	11065213	2038-08-23		Drug product	2021-07-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	11077073	2038-08-23	U-2224		2021-08-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	11077073	2038-08-23	U-3180		2021-08-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	11077073	2038-08-23	U-2106		2021-08-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	12233033	2038-08-23	U-2224		2025-03-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	12233033	2038-08-23	U-2106		2025-03-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208944-002	12233033	2038-08-23	U-3180		2025-03-25	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208944-001	8389578	2028-01-22	U-2105		2017-09-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208944-001	11197835	2030-12-02	U-2106		2022-01-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208944-001	8741343	2030-12-02	U-2106		2017-09-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208944-001	9867791	2030-12-02	U-2106		2018-01-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208944-001	9867792	2030-12-02	U-2106		2018-01-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208944-001	9867793	2030-12-02	U-2106		2018-01-16	`caaa826d4ba7…`

Observed Orange Book exclusivity history#

Exclusivity history page 3 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N208944-001	ODE-153	2024-08-24	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N208944-002	ODE-153	2024-08-24	`cb3db0bc1861…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 42 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
amantadine hydrochloride	AMANTADINE HYDROCHLORIDE	AvKARE	547904f3-84a3-1ccb-e063-6294a90a6fb6	2026-06-17	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	A-S Medication Solutions	da693bb0-0cc8-485d-89a7-c8cf28d440f3	2026-05-15	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Bryant Ranch Prepack	6326d7f5-4c7c-4541-8db1-c582f1525f60	2026-04-15	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
AMANTADINE HYDROCHLORIDE	AMANTADINE HYDROCHLORIDE	Cardinal Health 107, LLC	5989098d-2855-4b5f-9a06-64a83656c078	2026-04-08	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
AMANTADINE HYDROCHLORIDE	AMANTADINE HYDROCHLORIDE	Zhejiang Jutai Pharmaceutical Co., Ltd.	9c5e0c61-372b-4d1b-8882-e13f6af8fed0	2026-03-26	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Strides Pharma Inc.	e4d8f36f-d668-4728-8dca-b1c22bd9aedb	2026-01-30	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Major Pharmaceuticals	b2f7da34-ad78-4db3-9af1-bdd341e09f16	2026-01-05	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Chartwell Governmental & Specialty RX, LLC.	3c448cb3-7996-4a83-a9ad-23a00a431fbe	2025-12-19	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Strides Pharma Inc.	9a99bb98-82a4-4b9e-9216-554dade72a3c	2025-12-12	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Chartwell RX, LLC	52aa093c-82cc-4d81-b072-86a2b8adc9c5	2025-12-12	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Upsher-Smith Laboratories, LLC	63d9d4aa-5f92-45b0-98d0-d6ec38b727cb	2025-12-11	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Bryant Ranch Prepack	56b923c3-1d4a-47bf-9c9e-c0fdc54c8a2f	2025-10-24	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Bryant Ranch Prepack	96aefbca-fe71-42ef-8079-d0d9e7370ccb	2025-10-22	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Bryant Ranch Prepack	a10bf8b5-bf70-4090-b4b2-a0be252b9fe4	2025-10-22	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Marlex Pharmaceuticals Inc	25af52ee-9b29-4c07-a383-62d4537b63e0	2025-09-10	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	ST. MARY'S MEDICAL PARK PHARMACY	3dd7f2a6-5a91-81a2-e063-6294a90a33db	2025-09-02	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
AMANTADINE HYDROCHLORIDE	AMANTADINE HYDROCHLORIDE	PAI Holdings, LLC dba PAI Pharma	be411327-5ac7-46df-b5e4-32a11b419b15	2025-08-07	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
amantadine hydrochloride	AMANTADINE HYDROCHLORIDE	Bryant Ranch Prepack	8e578f11-6112-4a1f-8de4-a76870bb62c7	2025-07-14	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Advagen Pharma Limited	c3b9e7f0-be6d-4f37-9277-54bb0ba8b158	2025-07-09	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE
Amantadine Hydrochloride	AMANTADINE HYDROCHLORIDE	Upsher-Smith Laboratories, LLC	5232b933-1df9-43b4-8ac2-61bfa4855e68	2025-07-09	Warnings, Adverse reactions	Name fallback generic name: AMANTADINE HYDROCHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 10 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
70482-085	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-085	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-085	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-085	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-085	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-170	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-170	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-170	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-170	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current
70482-170	GOCOVRI	AMANTADINE	Adamas Pharma, LLC	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
82814	SUPPL	2025-07-11
82791	SUPPL	2025-07-11
66076	SUPPL	2021-02-03
66058	SUPPL	2021-02-02
62115	SUPPL	2020-03-11
62128	SUPPL	2020-03-10
54735	ORIG	2018-07-02
49540	ORIG	2017-08-25
49536	ORIG	2017-08-25